JNJ

Johnson & Johnson · NYSE:JNJ

273.20 USD−2.00 −0.73%

Johnson & Johnson (NYSE:JNJ) last traded at 273.20 USD, down 0.73% on the day. Over the past year the stock is up 46.03%. Its 52-week range is 185.12 to 282.01. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open280.00

Day range273.13 – 282.01

52-week range185.12 – 282.01

Volume8.97 M

Average volume (10 days)7.15 M

Market cap657.68 B

P/E41.44

EPS (TTM)6.59

Dividend yield1.93%

Beta (1 year)−0.4461

Revenue (TTM)99.35 B

Employees140.80 K

Performance

+2.78%1 week

+1.97%1 month

+6.71%3 months

+19.27%6 months

+32.10%Year to date

+46.03%1 year

Technical rating

Buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

283.24 USD

The average 1-year price target, +3.67% from the last price. See the forecast

Latest headlines

Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
Johnson & Johnson (JNJ) Reports Positive Real-World Impella HRPCI Outcomes vs CHIP-BCIS3TradingView · 01 Nov 2026
Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026
Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmarkMint · 29 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.